Cited by 2,513Lipoproteins and Cardiovascular HealthBiomarkers in Disease MechanismsInflammatory Biomarkers in Disease Prognosis

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention

Ridker, Paul M·2003·Circulation

Overview

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000053730.47739.3c

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 44 references

Research works printed but not linked: 9

  1. 10.1161/circ.103.13.1813 · DOI
  2. 10.1161/atvb.17.6.1121 · DOI
  3. 10.1161/circ.99.2.237 · DOI
  4. 10.1161/circ.97.20.2007 · DOI
  5. 10.1161/circ.100.7.717 · DOI
  6. 10.1161/circ.100.7.713 · DOI
  7. 10.1161/res.89.9.763 · DOI
  8. 10.1161/circ.100.3.230 · DOI
  9. 10.1161/circ.98.9.839 · DOI

Cited by

Sorted by citations

Items 901–1,000 of 1,001

Metadata

Authors
Ridker, P. M.
Affiliations
Brigham and Women's Hospital (US)
Corresponding author
Ridker, Paul M
Venue
Circulation
Published
2003-01-28
Volume
107
Issue
3
Pages
363-369
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2128722360
Cited by
2,513
References
44
Citations by year
2026: 56 · 2025: 70 · 2024: 72 · 2023: 66 · 2022: 75 · 2021: 82 · 2020: 91 · 2019: 98 · 2018: 100 · 2017: 98 · 2016: 110 · 2015: 134 · 2014: 117 · 2013: 126 · 2012: 125
FWCI
32.27
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl043851-10)
  • U.S. Public Health Service (L58755)
  • National Heart, Lung, and Blood Institute (HL43851, HL 63293, R01HL063293)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
Keywords
C-reactive protein, cardiovascular disease, cardiovascular risk prediction, inflammatory markers, atherosclerosis, cardiovascular disease prevention
MeSH terms
C-Reactive Protein, Cardiovascular Diseases, Cost-Benefit Analysis, Demography, Diabetes Mellitus, Type 2, Goals, Humans, Mass Screening, Risk Factors, Biomarkers, Practice Guidelines as Topic, Disease-Free Survival, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review